Target intelligence / Profile preview

Vaginal microenvironment pH (pH)

Target
pH
Molecular classification
Other, Physiological parameter
01

Overview

The vaginal microenvironment pH is a critical physiological parameter that defines the health and defensive capacity of the female reproductive tract. In healthy individuals of reproductive age, the pH is typically maintained in an acidic range between 3.8 and 4.5, primarily through the production of lactic acid by commensal Lactobacillus species (StatPearls, 2023). This acidic environment serves as a potent biological barrier, inhibiting the growth of opportunistic pathogens such as Gardnerella vaginalis and reducing the transmission of sexually transmitted infections like HIV and HSV-2 (PubMed, 2021). Disruptions in this balance, leading to an increase in pH, are associated with dysbiosis, most notably bacterial vaginosis, and can occur due to factors like menses, semen, or antibiotic use (NIH, 2022). Therapeutic targeting of the vaginal pH involves the application of acidifying agents or buffering systems to restore the natural acidic balance. For instance, products containing lactic acid, citric acid, and potassium bitartrate are utilized both for maintaining vaginal health and as non-hormonal contraceptives, as the acidic environment effectively immobilizes sperm (FDA, 2020). Additionally, boric acid is frequently employed as an antiseptic and acidifying agent for recurrent infections. Monitoring vaginal pH serves as a key diagnostic biomarker for identifying dysbiosis and evaluating the efficacy of intravaginal treatments.

Other names
Vaginal pHVaginal acidityVaginal hydrogen ion concentrationVaginal acid-base balance
02

Mechanism of action

Direct acidification and buffering of the vaginal lumen to maintain a protective pH range (3.5–4.5), which inhibits the growth of pathogenic anaerobes and immobilizes spermatozoa.

03

Biological functions

Immune responseAntimicrobial defenseMicrobiome homeostasisSperm motility regulationOther
04

Disease associations

InfectionBacterial vaginosisVulvovaginal candidiasisTrichomoniasisAtrophic vaginitisOther
05

Safety considerations

Vulvovaginal burningLocal irritationPruritusIncreased risk of vulvovaginal candidiasisDisruption of natural commensal flora
06

Interacting drugs

Lactic acid

4 more in the full profile.

07

Biomarkers

Vaginal pH levelNugent scoreAmsel criteriaLactobacillus abundance

Beyond the preview

Go deeper on Vaginal microenvironment pH (pH).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vaginal microenvironment pH (pH).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call